Regulatory Status NAD+ is a naturally occurring coenzyme that is marketed as a dietary-supplement ingredient in some contexts, but it is not an FDA-approved drug for any indication
Currently, there is no clinical research confirming that microdoses of tirzepatide can cause weight loss, improve glycemic control, or enhance metabolic health
All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals (National Academies Press, 2011) and approved by the Institutional Animal Care and Use Committee of Cornell University
By promoting healthy cellular turnover, it minimizes the chances of DNA damage and mutations that could lead to cancer
They also notice improvement in blood sugar levels, blood pressure, and cholesterol levels, along with weight loss
However, "better" depends on individual circumstances